Catalyst Wire Dossier Catalyst Wire Dossier

LYS228

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LYS228, covering 2019-10-08 to 2019-10-08. Get the full timeline:

Most recent: Clinical Trial Update: LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI) [Phase 2]

See pricing